Bio-Techne Corp. (TECH)
72.44
-0.14
(-0.19%)
USD |
NASDAQ |
Oct 06, 16:00
72.44
0.00 (0.00%)
After-Hours: 19:00
Bio-Techne Cash from Operations (Quarterly) : 95.42M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 95.42M |
| March 31, 2026 | 86.66M |
| December 31, 2025 | 82.41M |
| September 30, 2025 | 27.58M |
| June 30, 2025 | 98.20M |
| March 31, 2025 | 41.12M |
| December 31, 2024 | 84.35M |
| September 30, 2024 | 63.89M |
| June 30, 2024 | 75.50M |
| March 31, 2024 | 80.99M |
| December 31, 2023 | 83.12M |
| September 30, 2023 | 59.38M |
| June 30, 2023 | 83.39M |
| March 31, 2023 | 50.54M |
| December 31, 2022 | 64.38M |
| September 30, 2022 | 56.08M |
| June 30, 2022 | 102.72M |
| March 31, 2022 | 73.13M |
| December 31, 2021 | 100.99M |
| September 30, 2021 | 48.43M |
| June 30, 2021 | 122.02M |
| March 31, 2021 | 74.87M |
| December 31, 2020 | 89.27M |
| September 30, 2020 | 66.01M |
| June 30, 2020 | 44.79M |
| Date | Value |
|---|---|
| March 31, 2020 | 49.47M |
| December 31, 2019 | 70.42M |
| September 30, 2019 | 40.54M |
| June 30, 2019 | 55.95M |
| March 31, 2019 | 39.66M |
| December 31, 2018 | 46.56M |
| September 30, 2018 | 39.45M |
| June 30, 2018 | 64.84M |
| March 31, 2018 | 21.65M |
| December 31, 2017 | 39.18M |
| September 30, 2017 | 44.70M |
| June 30, 2017 | 50.85M |
| March 31, 2017 | 25.02M |
| December 31, 2016 | 41.63M |
| September 30, 2016 | 26.22M |
| June 30, 2016 | 36.36M |
| March 31, 2016 | 37.14M |
| December 31, 2015 | 38.54M |
| September 30, 2015 | 31.83M |
| June 30, 2015 | 37.14M |
| March 31, 2015 | 30.78M |
| December 31, 2014 | 35.28M |
| September 30, 2014 | 36.16M |
| June 30, 2014 | 37.84M |
| March 31, 2014 | 34.93M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Repligen Corp. | 32.77M |
| BioLife Solutions, Inc. | 6.348M |
| MindWalk Holdings Corp. | -2.895M |
| Maravai Lifesciences Holdings, Inc. | 3.992M |
| MaxCyte, Inc. | -4.661M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -7.057M |
| Cash from Financing (Quarterly) | -33.21M |
| Free Cash Flow | 263.22M |
| Free Cash Flow Per Share (Quarterly) | 0.5536 |
| Free Cash Flow to Equity (Quarterly) | 88.17M |
| Free Cash Flow to Firm (Quarterly) | 89.09M |
| Free Cash Flow Yield | 2.32% |